The results indicated that no noteworthy difference was found in associations of HOXB4 mRNA expression levels with gender and pathologic metastasis stage (M stage), although the higher HOXB4 mRNA expression level was observed in patients in the advanced tumor stage (T stage) and lymph node stage (N stage) in OS, DSS and PFI events (Figures 2E–J). The gene discussed is HOXB4; the disease is neoplasm.